Accordingly, it has been shown that cancer stem cells selected by the GalNAc-recognizing lectin Dolichos biflorus agglutinin (DBA) show similar characteristics to cells differentiated according to the CD133+ cell marker and form a cell in vivo [30]. The gene discussed is PROM1; the disease is cancer.